On the basis of our preliminary findings, we postulated that aspirin may exert its action via iPLA2 and have greater antitumor effect or require a lower dose for similar effect due to synthetic lethality in cancer cells with a baseline down-regulated AAM pathway. Here, PLA2G6 is linked to cancer.